Omstead, A. N., Zaidi, A. H., Kosovec, J. E., Matsui, D., Raj, M. S., Biederman, R. W. W., … Jobe, B. A. (2016). A preclinical study of a PI3K/mTOR dual inhibitor in the treatment of esophageal adenocarcinoma. In Journal of Clinical Oncology (Vol. 34, pp. e15554–e15554). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2016.34.15_suppl.e15554

Omstead, Ashten N., Ali Hussainy Zaidi, Juliann E. Kosovec, Daisuke Matsui, Moses S. Raj, Robert W. W. Biederman, Gene Grant Finley, Ronan Joseph Kelly, and Blair A. Jobe. “A preclinical study of a PI3K/mTOR dual inhibitor in the treatment of esophageal adenocarcinoma.” In Journal of Clinical Oncology, 34:e15554–e15554. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.e15554.

Omstead AN, Zaidi AH, Kosovec JE, Matsui D, Raj MS, Biederman RWW, et al. A preclinical study of a PI3K/mTOR dual inhibitor in the treatment of esophageal adenocarcinoma. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. e15554–e15554.

Omstead, Ashten N., et al. “A preclinical study of a PI3K/mTOR dual inhibitor in the treatment of esophageal adenocarcinoma.” Journal of Clinical Oncology, vol. 34, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2016, pp. e15554–e15554. Crossref, doi:10.1200/jco.2016.34.15_suppl.e15554.

Omstead AN, Zaidi AH, Kosovec JE, Matsui D, Raj MS, Biederman RWW, Finley GG, Kelly RJ, Jobe BA. A preclinical study of a PI3K/mTOR dual inhibitor in the treatment of esophageal adenocarcinoma. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. e15554–e15554.